Patient demographics and disease characteristics.
| Characteristics | Celecoxib, 50 mg bid, n = 101 | Celecoxib, 400/200 mg, n = 99 | Celecoxib, 800/400 mg, n = 98 | Indomethacin, 50 mg tid, n = 102 |
|---|---|---|---|---|
| Sex, n | ||||
| Men | 91 | 90 | 90 | 95 |
| Women | 10 | 9 | 8 | 7 |
| Age, yrs, n (%) | ||||
| 18–44 | 28 (27.7) | 28 (28.3) | 26 (26.5) | 34 (33.3) |
| 45–64 | 56 (55.4) | 55 (55.6) | 60 (61.2) | 54 (52.9) |
| ≥ 65 | 17 (16.8) | 16 (16.2) | 12 (12.2) | 14 (13.7) |
| Mean (SD) | 52.4 (11.9) | 52.3 (12.0) | 51.0 (11.3) | 49.6 (12.7) |
| Range | 28–80 | 25–90 | 26–79 | 23–76 |
| Race, n (%) | ||||
| White | 53 (52.5) | 64 (64.6) | 54 (55.1) | 55 (53.9) |
| Black | 11 (10.9) | 3 (3.0) | 10 (10.2) | 9 (8.8) |
| Asian | 22 (21.8) | 18 (18.2) | 19 (19.4) | 19 (18.6) |
| Other | 15 (14.9) | 14 (14.1) | 15 (15.3) | 19 (18.6) |
| Body mass index, kg/m2 | ||||
| Mean (SD) | 30.2 (5.7) | 30.3 (5.1) | 31.2 (7.1) | 30.6 (5.9) |
| Range | 14.5–45.7 | 19.6–47.8 | 20.1–64.7 | 17.3–47.4 |
| n* | 99 | 97 | 97 | 102 |
| Gout pattern, n (%) | ||||
| Monoarticular | 82 (81.2) | 78 (78.8) | 72 (73.5) | 78 (76.5) |
| Oligoarticular | 19 (18.8) | 21 (21.2) | 26 (26.5) | 24 (23.5) |
| Diabetes† | 10 | 6 | 10 | 5 |
| Hypertension†† | 45 | 45 | 39 | 45 |
| Angina pectoris | 1 | 1 | 0 | 3 |
↵* No. patients for whom body mass index data were available.
↵† No. patients with this condition; includes the following preferred terms: diabetes mellitus, type 2 diabetes mellitus, and diabetic neuropathy.
↵†† No. patients with this condition; includes the following preferred terms: hypertension and essential hypertension. Bid: twice daily; tid: 3 times daily.